RE: "Steep premium"9 May 2023 14:49
Clearly others have a different opinion.
"Kelso notes the Bloomberg Intelligence comment this morning and the subsequent significant fall in the THG share price. Kelso is of the opinion that the article headline of ‘THG unlikely to close a deal with Apollo seeing a profitable exit’ published this morning, could have been clearer and may have resulted in some confusion around THG. Kelso also notes that the Bloomberg analysts, in the article, attribute a sum of the parts value of £2.7bn to THG, c195p a share based on the number of shares in issue, more than double the current share price, which concurs with Kelso's view. The article went on to say that the THG board will not accept this price given the declined 170p per share bid last year and Apollo's need to buy at a sizeable discount to current fair value. Kelso is of the opinion that these points may not be correct and but do in fact reaffirm the underlying value of THG and the reason that Apollo is reviewing the business.
Whether or not Apollo ends up bidding for THG, we’ll all have to wait and see, but given Kelso's view of the strategic value of both THG’s nutrition and beauty businesses, as per the previous RNS of 21 April 2023, the board of Kelso would be very surprised if there were not multiple potential parties assessing THG as a whole or in part. Under UK Takeover rules, if there are no longer talks with Apollo then we understand that there has to be an announcement to the market immediately. If there are new multiple approaches for all or part of THG we would not necessarily expect to be formally informed.
Kelso also reaffirms its view of the fundamental value in THG, especially with the tailwinds the business is experiencing. Irrespective of the outcome of this process, Kelso firmly believe that in time this value will be unlocked, and this current interest from Apollo has strengthened our conviction."